Quinidine clinical trials
Its developmentBy 4 companies, company by company17 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.Counted the way a researcher would: Quinidine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Quinidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Quinidine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 12 Jul 1950 · QUINIDINE GLUCONATE · NDA 007529 (FDA, Drugs@FDA; as quinidine gluconate)
- European Union
- 24 Jun 2013 · Nuedexta · EMEA/H/C/002560 (EMA; in a combination; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2015 (5)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 6
Otsuka Pharmaceutical Development & Commercialization, Inc. (13) · Boehringer Ingelheim (2) · Bristol-Myers Squibb (1) · University of Florida (1) · James Murrough (1) · Cady, Roger, M.D. (1) · Food and Drug Administration (FDA) (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)
Often tested with
Tested in the same studies.
Deudextromethorphan (13) · Dextromethorphan (3) · Verapamil (2) · Dabigatran (2) · Dextromethorphan - quinidine combination (1) · Repotrectinib (1) · Voriconazole (1) · Paroxetine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Quinidine.
Studies
Open first, then newest update. How each study uses Quinidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsRecruitingPhase 1Trevi TherapeuticsNCT07946575Written as Quinidine SulfateHow we know
- Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular FibrillationEnrolling by invitationPhase 2Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT05593757Written as QuinidineHow we know
- Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of SchizophreniaTerminatedPhase 2/3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03896945Written as AVP-786How we know
- Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual SchizophreniaCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02477670Written as AVP-786How we know
- Safety, Tolerability and Efficacy of AVP-786 for the Treatment of DisinhibitionTerminatedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02534038Written as AVP-786How we know
- A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy VolunteersCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02174835Written as AVP-786How we know
- Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult SubejctsCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02402595Written as AVP-786How we know
- A Phase 1 Study Comparing AVP-786 With AVP-923CompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02336347Written as AVP-786How we know
- Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02446132Written as AVP-786How we know
- A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06493409Written as QuinidineHow we know
- Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04464564Written as AVP-786How we know
- Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04408755Written as AVP-786How we know
- Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03393520Written as AVP-786How we know
- Impact of Nuedexta on Bulbar Physiology and Function in ALSCompletedPhase 1/2University of FloridaNCT03883581Written as dextromethorphan HBr and quinidine sulfateHow we know
- Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02442765Written as AVP-786How we know
- Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive DisorderTerminatedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03420222Written as AVP-786How we know
- A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy SubjectsCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02174822Written as AVP-786How we know
- Empiric Quinidine for Asymptomatic Brugada SyndromeWithdrawnPhase 2/3International Registry of Asymptomatic Brugada SyndromeNCT00789165Written as quinidineHow we know
- Nuedexta in Treatment-Resistant Major DepressionCompletedPhase 2James MurroughNCT01882829Written as dextromethorphan/quinidineHow we know
- Nuedexta for the Prevention and Modification of Disease Progression in Episodic MigraineCompletedPhase 2Cady, Roger, M.D.NCT02176018Written as Dextromethorphan and quinidineHow we know
See all 23 studies that test Quinidine →
Given beside what is tested · 11 — Quinidine is usual care or a partner of the new treatment
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT06704763Written as QuinidineHow we know
- A Study of Imlunestrant (LY3484356) in Female Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT05444556Written as QuinidineHow we know
- A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.CompletedPhase 1AstraZenecaNCT06979388Written as quinidineHow we know
- A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With QuinidineCompletedPhase 1AstraZenecaNCT06974565Written as QuinidineHow we know
- A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.CompletedPhase 1Enanta Pharmaceuticals, IncNCT06847464Written as QuinidineHow we know
- Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.CompletedPhase 1Enanta Pharmaceuticals, IncNCT05594602Written as QuinidineHow we know
- Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy SubjectsCompletedPhase 1Enanta Pharmaceuticals, IncNCT04783753Written as QuinidineHow we know
- Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy MalesCompletedPhase 1CelgeneNCT01712828Written as QuinidineHow we know
- Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy SubjectsCompletedPhase 1Enanta Pharmaceuticals, IncNCT03755778Written as QuinidineHow we know
- Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy VolunteersCompletedPhase 1Enanta Pharmaceuticals, IncNCT03610945Written as QuinidineHow we know
- Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118CompletedPhase 1AstraZenecaNCT01533155Written as QuinidineHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
Codes
What other systems call Quinidine · ClinicalTrials.gg INT008144
- MeSH (NLM) D011802QuinidineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) ITX08688JLQUINIDINEConfirmed FDA, NLM, Wikidata
- RxNorm 9068Confirmed FDA, Wikidata
- Wikidata Q412496quinidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C793QuinidineOne source FDA
- DrugBank DB00908One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011802 | Quinidine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | ITX08688JL | QUINIDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9068 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412496 | quinidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C793 | Quinidine | One source FDA |
| DrugBank | DB00908 | — | One source Wikidata |
Also registered as quinidine sulfate (UNII J13S2394HE · RxNorm 9069).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.